GI
PHAT icon

GAMMA Investing’s Phathom Pharmaceuticals PHAT Stock Holding History

GAMMA Investing’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.34K Sell
400
-38
-9% -$434 ﹤0.01% 3528
2026
Q1 		$4.87K Buy
438
+135
+45% +$1.71K ﹤0.01% 3371
2025
Q4 		$5.03K Sell
303
-57
-16% -$814 ﹤0.01% 3267
2025
Q3 		$4.24K Buy
360
+336
+1,400% +$3.47K ﹤0.01% 3241
2025
Q2 		$230 Sell
24
-703
-97% -$3.89K ﹤0.01% 3712
2025
Q1 		$4.56K Buy
727
+219
+43% +$1.33K ﹤0.01% 3121
2024
Q4 		$4.13K Buy
508
+354
+230% +$4.38K ﹤0.01% 2994
2024
Q3 		$2.78K Buy
154
+147
+2,100% +$2.06K ﹤0.01% 2956
2024
Q2 		$72 Sell
7
-16
-70% -$165 ﹤0.01% 3415
2024
Q1 		$244 Buy
23
+16
+229% +$136 ﹤0.01% 3207
2023
Q4 		$47 Buy
+7
New +$60 ﹤0.01% 3161

Other funds holding PHAT

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
PMAM
Penn Mutual Asset Management Conshohocken, Pennsylvania $19.5M AUM 3.07% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SFWA
Summit Financial Wealth Advisors Lafayette, Louisiana $782M AUM 24.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

GAMMA Investing's PHAT Position: Q2 2026 in Review

GAMMA Investing reduced its Phathom Pharmaceuticals (PHAT) stake by 8.7% in Q2 2026, selling an estimated $434 and leaving 400 shares worth $4.34K. The position accounts for ﹤0.01% of the portfolio, ranked #3528.

GAMMA Investing first reported a position in PHAT in Q4 2023 and has held it in 11 quarters since. The position peaked at $5.03K in Q4 2025. 16 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • GAMMA Investing held 400 shares of Phathom Pharmaceuticals worth $4.34K as of Q2 2026.
  • GAMMA Investing sold 38 Phathom Pharmaceuticals shares in Q2 2026, an estimated $434.
  • Phathom Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3528 holding.
  • GAMMA Investing first reported a position in Phathom Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Phathom Pharmaceuticals position peaked at $5.03K in Q4 2025.
  • 16 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.